Pankit Vachhani, MD

home / authors / pankit-vachhani-md

Pankit Vachhani, MD, is an associate professor of medicine at the University of Alabama at Birmingham.

Articles

June 29th 2025

Post Hoc Analysis Findings Offer Guidance for Anemia Management in Myelofibrosis: Pankit Vachhani, MD

A post hoc analysis of the phase 3b JUMP trial supports the real-world use of ruxolitinib with anemia supportive care to maintain dosing and clinical outcomes in patients with myelofibrosis, offering a practical strategy that does not compromise efficacy.

June 28th 2025

Ruxolitinib Plus Anemia Supportive Care Maintains Efficacy in Myelofibrosis: Pankit Vachhani, MD

Brooke McCormick Pankit Vachhani, MD

A post-hoc analysis of the phase 3b JUMP trial found that ruxolitinib plus anemia supportive care maintained efficacy and reduced transfusion needs in patients with myelofibrosis.

June 26th 2025

Post-Hoc Analysis Evaluates Ruxolitinib Plus Anemia-Supportive Therapies in Myelofibrosis: Pankit Vachhani, MD

Brooke McCormick Pankit Vachhani, MD

A post-hoc analysis of the phase 3b JUMP trial assessed outcomes in patients with myelofibrosis and baseline anemia who were treated with ruxolitinib alongside anemia-supportive therapies, according to Pankit Vachhani, MD.